ID

4471

Beskrivning

A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer Inclusion Criteria: - Diagnosis of prostate cancer. - Rising PSA while on hormonal therapy or following surgical castration. - Documented evidence of metastatic disease. Exclusion Criteria: - Have received cytotoxic chemotherapy. - Have received opioid or narcotic medications (such as codeine or morphine) or radiation for pain caused by your prostate cancer in the last 6 months

Nyckelord

Versioner (1)
  1. 2013-12-09 2013-12-09 - Martin Dugas
Uppladdad den

9 december 2013

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0 Legacy
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility DRKS00009647 NCT00036543 Prostate Cancer

Tysk Engelsk

Eligibility

1 Formulär  
  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion criteria
Beskrivning

Inclusion criteria

Diagnosis of prostate cancer
Beskrivning

Diagnosis

Datatyp

boolean

Rising PSA while on hormonal therapy or following surgical castration
Beskrivning

PSA

Datatyp

boolean

Documented evidence of metastatic disease
Beskrivning

Metastasis

Datatyp

boolean

Exclusion criteria
Beskrivning

Exclusion criteria

Have received cytotoxic chemotherapy
Beskrivning

Chemotherapy

Datatyp

boolean

Have received opioid or narcotic medications (such as codeine or morphine) or radiation for pain caused by your prostate cancer in the last 6 months
Beskrivning

Pain by Prostate Cancer

Datatyp

boolean

Medical Concepts
Beskrivning

Medical Concepts

Diagnosis
Beskrivning

Diagnosis

Datatyp

string

Alias
UMLS CUI
C0011900
SNOMED CT 2010_0731
439401001
PSA
Beskrivning

Prostate-Specific Antigen

Datatyp

string

Alias
UMLS CUI
C0138741
SNOMED CT 2010_0731
102687007
Metastatic malignant disease
Beskrivning

Secondary malignant neoplastic disease

Datatyp

string

Alias
UMLS CUI
C0027627
SNOMED CT 2010_0731
128462008
Cancer chemotherapy
Beskrivning

Chemotherapy

Datatyp

string

Alias
UMLS CUI
C0392920
SNOMED CT 2010_0731
150415003
Medication
Beskrivning

Pharmaceutical Preparations

Datatyp

string

Alias
UMLS CUI
C0013227
Radiotherapy
Beskrivning

Radiotherapy

Datatyp

string

Alias
UMLS CUI
C1522449
SNOMED CT 2010_0731
302505005
Tillbaka till toppen

Similar models

Eligibility

1 Formulär
  1. StudyEvent: Eligibility
    1. Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Inclusion criteria
Diagnosis
Item
Diagnosis of prostate cancer
boolean
PSA
Item
Rising PSA while on hormonal therapy or following surgical castration
boolean
Metastasis
Item
Documented evidence of metastatic disease
boolean
Item Group
Exclusion criteria
Chemotherapy
Item
Have received cytotoxic chemotherapy
boolean
Pain by Prostate Cancer
Item
Have received opioid or narcotic medications (such as codeine or morphine) or radiation for pain caused by your prostate cancer in the last 6 months
boolean
Item Group
Medical Concepts
Diagnosis
Item
Diagnosis
string
C0011900 (UMLS CUI)
439401001 (SNOMED CT 2010_0731)
Prostate-Specific Antigen
Item
PSA
string
C0138741 (UMLS CUI)
102687007 (SNOMED CT 2010_0731)
Secondary malignant neoplastic disease
Item
Metastatic malignant disease
string
C0027627 (UMLS CUI)
128462008 (SNOMED CT 2010_0731)
Chemotherapy
Item
Cancer chemotherapy
string
C0392920 (UMLS CUI)
150415003 (SNOMED CT 2010_0731)
Pharmaceutical Preparations
Item
Medication
string
C0013227 (UMLS CUI)
Radiotherapy
Item
Radiotherapy
string
C1522449 (UMLS CUI)
302505005 (SNOMED CT 2010_0731)
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial